How to Buy Moderna Stock
Moderna Inc
Moderna, Inc. , a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally.
Moderna stock last closed at $101.41, down 0.58% from the previous day, and has decreased 28.99% in one year. It has underperformed other stocks in the Biotechnology industry by 0.04 percentage points. Moderna stock is currently +62.13% from its 52-week low of $62.55, and -28.99% from its 52-week high of $142.82.
There are currently 382.07M MRNA shares outstanding. The market value of MRNA is $38.75B. In the past 24 hours, 2.61M MRNA shares were traded.
How to Buy Moderna Stock
Not sure how to invest in Moderna stock? Here's how.
- Decide where to buy Moderna stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Moderna stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your investment account: Select your payment method and add your information.
- Research Moderna stock: The Moderna ticker symbol is MRNA. Is Moderna stock a good investment? Should you buy shares of MRNA? How do MRNA's underlying business fundamentals look? Do top analysts think Moderna is a good buy? Why has MRNA's stock price moved recently? (Hint: Our stock market research website can help you figure out if MRNA is a good stock to buy).
- Make your MRNA purchase: Decide if you will purchase MRNA shares at the current market price or use a limit order to buy MRNA shares at a given price.
- Track your MRNA investment: Create a watchlist to keep track of your position in Moderna shares.
Step 1: Decide where to buy Moderna stock
You will need a brokerage account to access the NASDAQ market and buy MRNA stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Technology to Financial Services, New York to Tokyo — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro today.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal info so you can buy MRNA today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to start a new trading account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've opened your account on the best beginner stock app, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help transferring funds into your investment account.
Step 4: Research Moderna stock
Once you have chosen the best place to buy Moderna stock, it's important to analyze their stock before you invest, so you actually comprehend the risk as well as the opportunity.
Moderna quick stats
Moderna Fundamentals
WallStreetZen was built to help part-time investors do better fundamental analysis quickly.
You can see all of the due diligence checks on MRNA's stock page.
How is MRNA stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge MRNA's intrinsic value.
Using relative valuations methods:
- MRNA may be undervalued based on its P/B ratio of 2.8x, relative to Biotechnology industry P/B ratio of 5.74x
You can do more valuation analysis on MRNA's stock here.
A quick look at MRNA Financials
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the MRNA balance sheet.
- MRNA has cash burn of 3825000000. It has enough cash and short-term investments to cover this for at least one year.
- MRNA has a low debt to equity ratio of 0.33.
- MRNA has $8.60B in cash and short term investments. This is enough to cover its annual cash burn of $3.83B.
- There are more short-term assets than short-term liabilities on the MRNA balance sheet.
Failed Financial Due Diligence Checks:
- MRNA profit margin has gone down from 43.4% to -68.8% in the past year.
- Total MRNA debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy MRNA stock, according to Wall Street analysts?
Out of 7 sell side analysts who research MRNA, the consensus analyst rating on Moderna is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent MRNA Analyst Upgrades/Downgrades
Jessica Fye, a top 12% analyst from JP Morgan maintains MRNA with a hold rating and lowers their MRNA price target from $93.00 to $90.00, on Dec 1, 2023.
Salveen Richter, a top 30% analyst from Goldman Sachs maintains MRNA with a strong buy rating and lowers their MRNA price target from $269.00 to $231.00, on Nov 3, 2023.
You can dig deeper into what analysts are forecasting on the Moderna stock forecast page.
MRNA Momentum
Is MRNA Making Money?
Last year, MRNA revenue was $6.85B. Over the past 5 year, MRNA's revenue has grown by 119.28% per year. This was faster than the Biotechnology industry average of 28.92%.
You can research MRNA's earnings and revenue performance here.
Are MRNA insiders buying or selling the stock?
In the last 12 months, executives and large shareholders at MRNA have sold more shares than they have bought.
Noubar Afeyan, Director of MRNA, was the latest MRNA insider to sell. They sold $29,466.18 worth of MRNA shares on Apr 17, 2024.
Research more about who owns MRNA stock here.
Can I rely on MRNA as an income stream?
No, Moderna doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your MRNA purchase
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact price, use a limit order.
Click the Open button and your broker will place your order.
If you want additional assistance buying stocks on eToro, click the how to video below:
Step 6: Track your MRNA investment
Now that you own some shares in MRNA, you'll want to keep up with your new stock purchase.
Put MRNA on a watchlist to get notified of important updates regarding your MRNA stock.
MRNA Feed
How to Buy Stock in Moderna
To summarize, here are the 6 steps to buy Moderna stock:
- Decide where to buy Moderna stock
- Open a brokerage account
- Fund your investment account
- Research Moderna stock
- Make your MRNA purchase
- Track your MRNA investment
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep tabs on your new investment in Moderna, click below.
Other Articles You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.